Medtronic (MDT) Stock Forecast & Price Target

Medtronic
Bear Case

Investors should be bearish about investing in Medtronic plc for these reasons:

• Despite recent earnings beats, the stock price has experienced significant volatility and drawdowns, having fallen from highs near $106 to the current $88.02, which may reflect ongoing concerns about the company's growth trajectory or valuation multiples that deter some investors.
• Short interest in Medtronic plc has increased recently, with shares shorted rising to 17.23 million as of the latest record date, representing a month-to-month increase of 4.2%, which suggests that a portion of the market is betting against the stock's future performance.
• Recent insider activity shows selling pressure, with EVP Harry Skip Kiil selling 1,483 shares at an average price of $93.65 in September 2026, following larger sales in previous months, which can be interpreted as a lack of confidence from company leadership at current price levels.
• Some institutional investors have reduced their positions in the company, such as Park National Corp OH, which lowered its stake by 12.0% in the third quarter, and CX Institutional, which cut its position by 89.0%, indicating that some large holders are taking profits or reallocating capital away from Medtronic plc.
• The company's valuation, with a P/E ratio of 21.68, may be considered high relative to its historical averages or peers, particularly if the recent revenue growth of 13.7% is not sustained, posing a risk of multiple compression if future earnings disappoint.